Loading...

EKSO EKSO BIONICS HOLDINGS INC Capital Structure Changes 8-K Filing

KS B

KS

EKSO BIONICS HOLDINGS INC

(EKSO)

2025 8-K

Executive Compensation Changes

Equity Offering Report

Financial Results

Loan Agreement Secured

Financial Statements

Reverse Stock Split

Financial Statements

Warrant Agreement

Financial Results

Q4 2024 Results

Nasdaq Compliance Notice

Financial Results

Public Offering

Financial Results

Amendment to Initial 8-K

Annual Meeting of Stockholders

Financial Results

Financial Results Announcement

Securities Purchase Agreement

Financial Statements and Ex...

Financial Results Announcement

Compliance with Minimum Bid...

Agreement and Non-complianc...

Loan Agreement Amendment

Financial Results

Amendment to At the Market ...

Financial Results

Departure of Director, CEO ...

Financial Results

External Links:

On October 28, 2025, Ekso Bionics Holdings, Inc. reported a securities purchase agreement to sell 769,490 shares at $4.81 each, raising approximately $3.2 million for corporate purposes. The offering is set to close around October 30, 2025.

AI Assistant

EKSO BIONICS HOLDINGS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.